Please provide your email address to receive an email when new articles are posted on . Down syndrome remained a significant risk factor for pediatric leukemia, especially acute myeloid leukemia, ...

– Encouraging clinical activity with deep responses demonstrated in the KOMET-007 trial with the combination of 600 mg ziftomenib with 7+3 in newly diagnosed patients with NPM1-m and KMT2A-r AML – – ...

CLEVELAND, May 31, 2017 /PRNewswire-USNewswire/ -- AML RightSource, a Gabriel Partners Company, is pleased to announce its affiliate membership with the Association of Certified Financial Crime ...

Activity of the mitochondrial metabolism inhibitor cpi-613 in combination with high dose Ara-C (HDAC) and mitoxantrone in high risk relapsed or refractory acute myeloid leukemia (AML). This is an ASCO ...

The mTORC1 signaling pathway is constitutively activated in almost all acute myelogenous leukemia (AML) patients. We conducted a phase Ib trial combining RAD001 (everolimus), an allosteric inhibitor ...

MEXICO CITY, Nov. 4, 2025 /PRNewswire/ -- With the firm purpose of strengthening their capabilities in preventing money laundering (AML) and other illicit activities, Mexican banks will implement a ...

AML Watcher joins the Hong Kong FinTech Association, strengthening AML compliance innovation and expanding its global fintech Network in the APAC region. “This partnership connects us to a rich ...

Abhishek Bali, CEO & Co-founder, ZIGRAM. "Our collaboration with PSPAN represents a meaningful step in enabling Nepal’s payment ecosystem to access world-class AML technologies tailored for local ...

The paper provides internal auditors within Singapore’s banks and external auditors who work with banks with a common framework to formulate and execute audits pertaining to AML/CFT. The Association ...

AML Watcher joins the Singapore FinTech Association to drive AML innovation, expand globally, and simplify compliance for financial institutions. This partnership reflects our belief that meaningful ...